AltheaDx Castle Biosciences to Acquire AltheaDx for $65M Castle said the move furthers its mid- and long-term growth plans with a strategic advance into pharmacogenomics and mental health. Local Coverage Determinations Roundup: Myriad, AltheaDx, Castle Bio, Razor Genomics, and More A bi-weekly listing of recent local coverage determinations from Medicare Administrative Contractors. Local Coverage Determinations Roundup: MDxHealth, Myriad, AltheaDx, Natera, and More AltheaDx Closes $27M Series D Round The financing, which comes on the heels of a $30 million Series C round, will be used for operating capital. AltheaDx Closes $30M Series C Financing Round The funding comes several months after the drug metabolism testing company withdrew a planned $74.3 million initial public offering. Aug 11, 2015 AltheaDx, Sinfonia Partner on Mental Health Mar 9, 2015 AltheaDx Withdraws IPO Jan 26, 2015 AltheaDx Increases Target Amount on Proposed IPO to $74.3M Dec 23, 2014 MDx Firm AltheaDx Files for $69M IPO Oct 8, 2014 People in the News: Nicolas Barthelemy, Richard Ding, Bruce Bodaken, Karin Eastham, Jorge Garces Premium Sep 29, 2014 NYDOH Approves AltheaDx's PGx Test Suite Jul 21, 2014 AltheaDx Receives CAP Accreditation Oct 8, 2013 Life Tech Certifies 11 Additional Labs to Provide Ion Proton Exome Sequencing Services Feb 8, 2012 Life Tech Certifies Asuragen, AltheaDx as Service Providers for Sequencing on PGM Premium Feb 6, 2012 AltheaDx Named Ion Torrent CSP Jul 6, 2011 AltheaDx Explores Desktop NGS Platforms for Cancer Gene Panels Premium Jun 29, 2011 AltheaDx Adds Next-Gen Sequencing Services for Biomarker Discovery, Clinical Trial Testing Premium Mar 22, 2011 Experts Debate Clinical Sequencing's Short- and Long-Term Impact on Dx, Therapeutics, Patient Health Premium Dec 8, 2010 AltheaDx, Compendia Partner on Breast Cancer Assay Apr 19, 2010 AltheaDx Teams with Institute on Pediatric Cancer MDx Apr 13, 2010 AltheaDx Nets $6M in Series A Financing Breaking News GA4GH Announces 10 New 'Driver' Projects, Including First Pediatric Partner Single-Cell MRD Assay Helps Characterize Cells Surviving Acute Myeloid Leukemia Therapy Research Triangle Institute Partners With GeneDx, Illumina for Expanded Newborn Screening Study Bionano Genomics' Third Chinese OEM Partner Gets NMPA Nod for Sample Prep Product InformedDNA Buys gWell Health, Names New CEO The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.